China Universal Asset Management Company’s Century Therapeutics IPSC Stock Holding History

China Universal Asset Management Company’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,528	Closed	-$3.06K	–	457
2023 Q3	$3.06K	Buy	1,528 +747	+96%	+$1.99K	﹤0.01%	415
2023 Q2	$2.47K	Sell	781 -18	-2%	-$58	﹤0.01%	417
2023 Q1	$2.77K	Buy	799 +200	+33%	+$878	﹤0.01%	420
2022 Q4	$3.07K	Buy	599 +48	+9%	+$453	﹤0.01%	343
2022 Q3	$5K	Buy	+551	New	+$5.8K	﹤0.01%	272

Other funds holding IPSC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

China Universal Asset Management Company's IPSC Position: Q4 2023 in Review

China Universal Asset Management Company sold out of Century Therapeutics (IPSC) in Q4 2023, closing a stake of 1,528 shares — an estimated $3.06K sold.

China Universal Asset Management Company first reported a position in IPSC in Q3 2022 and held it in 5 quarters. The position peaked at $5K in Q3 2022. 63 funds tracked by Wall St. Rank hold IPSC as of Q4 2023.

China Universal Asset Management Company reported no remaining Century Therapeutics position as of Q4 2023 after selling out during the quarter.
China Universal Asset Management Company sold 1,528 Century Therapeutics shares in Q4 2023, an estimated $3.06K.
China Universal Asset Management Company first reported a position in Century Therapeutics in Q3 2022 and held it in 5 quarters.
China Universal Asset Management Company's Century Therapeutics position peaked at $5K in Q3 2022.
63 funds tracked by Wall St. Rank held Century Therapeutics as of Q4 2023.

Based on China Universal Asset Management Company's 13F filing for Q4 2023, filed 24 Jan 2024.